RICE HALL JAMES & ASSOCIATES, LLC – Supernus Pharmaceuticals, Inc. Transaction History
RICE HALL JAMES & ASSOCIATES, LLC portfolio value:
$22.99M
portfolio value
RICE HALL JAMES & ASSOCIATES, LLC quarter portfolio value change:
+17.05%
quarter
Supernus Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -18.54% | -154.64K shares | -1.12M | $33.85 | 679.31K |
| Q2 2022 | share | Decrease | -2.46% | -20.99K shares | -3.51M | $28.92 | 833.95K |
| Q1 2022 | share | Decrease | -0.22% | -1.90K shares | 2.64M | $32.32 | 854.94K |
| Q4 2021 | share | Decrease | -6.34% | -58.02K shares | 586K | $30.03 | 856.85K |
| Q3 2021 | share | Decrease | -0.86% | -7.97K shares | -4.01M | $26.67 | 914.88K |
| Q2 2021 | share | Decrease | -10.84% | -112.23K shares | 1.31M | $30.79 | 922.85K |
| Q1 2021 | share | Decrease | -0.22% | -2.28K shares | 999K | $26.18 | 1.03M |
| Q4 2020 | share | Increase | +2.75% | 27.76K shares | 5.06M | $25.16 | 1.03M |
| Q3 2020 | share | Increase | +9.09% | 84.12K shares | -940K | $20.84 | 1.00M |
| Q2 2020 | share | Decrease | -2.33% | -22.06K shares | 4.93M | $23.75 | 925.48K |
| Q1 2020 | share | Decrease | -1.50% | -14.41K shares | -5.77M | $17.99 | 947.55K |
| Q4 2019 | share | Increase | +2.66% | 24.9K shares | -2.93M | $23.72 | 961.97K |
| Q3 2019 | share | Decrease | -30.65% | -414.21K shares | -18.96M | $27.48 | 937.07K |
| Q2 2019 | share | Increase | +35.08% | 350.90K shares | 9.66M | $33.09 | 1.35M |
| Q1 2019 | share | Increase | +9.48% | 86.64K shares | 4.69M | $35.04 | 1.00M |
| Q4 2018 | share | Increase | +43.02% | 274.84K shares | -1.81M | $33.22 | 913.73K |
| Q3 2018 | share | Decrease | -20.40% | -163.76K shares | -15.87M | $50.35 | 638.89K |
| Q2 2018 | share | Decrease | -38.34% | -499.06K shares | -11.58M | $59.85 | 802.66K |
| Q1 2018 | share | Decrease | -1.58% | -20.88K shares | 6.91M | $45.8 | 1.30M |
| Q4 2017 | share | Increase | +8.03% | 98.29K shares | 3.73M | $39.85 | 1.32M |
| Q3 2017 | share | Decrease | -10.07% | -137.05K shares | -9.70M | $40 | 1.22M |
| Q2 2017 | share | Increase | +24.51% | 267.97K shares | 24.45M | $43.1 | 1.36M |
| Q1 2017 | share | Increase | +1.08% | 11.66K shares | 6.90M | $31.3 | 1.09M |
| Q4 2016 | share | Increase | +79.02% | 477.49K shares | 12.37M | $25.25 | 1.08M |
| Q3 2016 | share | Increase | +11.15% | 60.63K shares | 3.87M | $24.73 | 604.24K |
| Q2 2016 | share | Increase | +1.33% | 7.16K shares | 2.89M | $20.37 | 543.60K |
| Q1 2016 | share | Increase | +12.45% | 59.37K shares | 1.76M | $15.25 | 536.44K |